CFFN
Capitol Federal Financial, Inc.
CFFN's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 45%. At 13x earnings, it's trading below its usual 16x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CFFN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CFFN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CFFN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CFFN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $8.46 | — |
| Cheap | 13x | $8.40 | -0.7% |
| Current | 13x | $8.46 | — |
| Fair | 15x | $10.01 | +18% |
| Expensive | 21x | $13.83 | +63% |
Historical ranges are pointers, not guarantees.
CFFN's PE is in its cheap range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CFFN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
CFFN has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CFFN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.78 | +19% |
| Q2 2026 | $0.65 | +38% |
| Q1 2026 | $0.60 | +50% |
| Q4 2025 | $0.56 | +44% |
| Q3 2025 | $0.52 | +79% |
| Q2 2023 | $0.43 | -31% |
| Q1 2023 | $0.53 | -10% |
| Q4 2022 | $0.58 | 0% |
| Q3 2022 | $0.62 | +11% |
CFFN has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CFFN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $60.2M | +19% |
| Q1 2026 | $57.7M | +18% |
| Q4 2025 | $56.8M | +21% |
| Q3 2025 | $54.6M | +20% |
| Q2 2025 | $50.7M | +13% |
| Q1 2025 | $48.8M | +6.2% |
| Q4 2024 | $46.9M | +53% |
| Q2 2024 | $45M | +11% |
CFFN's revenue has grown year over year for eight quarters in a row: $60M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 49% | +6 points |
| Q1 2026 | 43% | +4 points |
| Q4 2025 | 44% | +3.7 points |
| Q3 2025 | 42% | +0.1 points |
| Q2 2025 | 43% | +8 points |
| Q1 2025 | 39% | +2 points |
| Q4 2024 | 41% | +34 points |
| Q3 2024 | 42% | N/A |
CFFN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CFFN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $15.7M | +46% |
| Q1 2026 | $20.1M | +37% |
| Q4 2025 | $15.8M | +255% |
| Q3 2025 | $19.9M | +$24.7M |
| Q2 2025 | $10.8M | -35% |
| Q1 2025 | $14.7M | -23% |
| Q4 2024 | $4.5M | +$11.1M |
| Q2 2024 | $16.4M | +128% |
CFFN has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CFFN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -2.6M shares |
| 1 year | -4.7% | -6.1M shares |
| 3 years | -6.9% | -9.1M shares |
| 5 years | -8.5% | -11.5M shares |
| Available history | -10% | -13.9M shares |
CFFN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $15.8M |
| Q4 2025 | $16M |
| Q3 2025 | $3.9M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $1,000 |
CFFN spent $50M buying back its own shares over the past year, more than ten times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CFFN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -3.2x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q3 2025 | 18.7x | High |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -4.2x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | 31.3x | High |
CFFN has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CFFN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 39.0 | Neutral |
CFFN's weekly RSI is 54 (neutral) and its Stochastic is 39 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CFFN PE vs Financial Services Sector
| Metric | CFFN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | Same PE |
| PE % | 19 | 63 | 44 pts below |
CFFN is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CFFN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.44 | 0.2% above |
| 20 week MA | $8.60 | 1.6% below |
| 50 week MA | $7.87 | 7.5% above |
| 100 week MA | $6.92 | 22% above |
| 200 week MA | $6.51 | 30% above |
CFFN has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CFFN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $12.4 | -9.8% |
| 2021 | $12.4 | $11.4 | -8.2% |
| 2022 | $11.4 | $8.60 | -24% |
| 2023 | $8.60 | $6.45 | -25% |
| 2024 | $6.45 | $5.95 | -7.8% |
| 2025 | $5.95 | $7.00 | +18% |
| 2026 YTD | $7.00 | $8.46 | +21% |
CFFN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.